“…After functional validation, we confirmed consistency in our RNA sequencing across sample pools by conducting principal component analysis and examining the expression of known positive (Shox2, Isl1, Tbx3, Hcn4, Flrt3, Lsps1) and negative (Nkx2.5, Scn5a, Bmp10, Gja5) markers of CPCs (Hoogaars et al, 2004(Hoogaars et al, , 2007Blaschke et al, 2007;Espinoza-Lewis et al, 2009;Wiese et al, 2009;Bakker et al, 2012;Ye et al, 2015aYe et al, , 2015bIonta et al, 2015;Liang et al, 2015Liang et al, , 2020Bressan et al, 2018;Li et al, 2019;van Eif et al, 2019;Thomas et al, 2021;Okada et al, 2022). Marker gene expression analysis indicated that all three sample pools showed similar fold differences in previously identified differentially expressed genes (Fig S1B ) and principal component analysis demonstrated strong separation between SAN and atrial sample pools (Fig S1C).…”